Stryker wins FDA clearance as Stryker stock trades at EUR 262.05

Published on 10/19/2026 at 09:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sonopet 3 won FDA clearance on October 14, 2026. Stryker stock costs EUR 262.05 on October 19, 2026, 0.21 percent above the Xetra close.

Product clearance and reporting dates

Sonopet 3 received FDA 510(k) clearance on October 14, 2026.
Second-quarter 2026 revenue reached USD 6.59 billion, up 9.40 percent year over year.
Stryker stock trades at EUR 262.05 at 9:50 a.m. CEST on October 19, 2026, 0.21 percent above the Xetra close of October 16, 2026.
Stryker is scheduled to report third-quarter results on October 29, 2026.

Isometrische Illustration der Wertschöpfungskette von Rohstoff bis Operationssaal — Isometrische 3D-Grafik zeigt die Wertschöpfungskette der Medizintechnik-Branche, in der Stryker Corp. US8636671013 tätig ist, Illustration mit AI erstellt.

Stryker Corporation (ISIN US8636671013) was trading at EUR 262.05 at Lang & Schwarz at 9:50 a.m. CEST on October 19, 2026, up 0.21 percent versus the Xetra close of October 16, 2026 at EUR 261.50. The medical technology company had received FDA 510(k) clearance for its Sonopet 3 surgical platform on October 14, 2026, according to PR Newswire.

What does Sonopet 3 add?

Sonopet 3 is an ultrasonic platform for removing bone and soft tissue. The product includes RISE for connected surgical workflows and Pulse Control for regulating tissue resection, while the first clinical cases are expected to begin in October. Stryker said the platform was developed with input from hundreds of surgeons, a product detail reported by PR Newswire.

Three events shape the setup

On July 30, 2026, Stryker reported second-quarter revenue of USD 6.59 billion, up 9.40 percent year over year, according to MarketBeat. On October 6, 2026, Truist Financial lowered its price target from USD 340.00 to USD 310.00 while retaining a Hold rating, the same report said. On October 14, 2026, Stryker received the Sonopet 3 clearance, creating the most recent product milestone.

Which dates matter next?

Stryker has scheduled its third-quarter 2026 earnings call for October 29, 2026 at 4:30 p.m. ET, according to the company event page from Stryker. The quarterly dividend of USD 0.88 per share is scheduled for payment on October 30, 2026, according to MarketBeat.

Stock price holds above the Xetra close

The euro quotation was EUR 262.05 at Lang & Schwarz at 9:50 a.m. CEST on October 19, 2026, or plus 0.21 percent versus the Xetra close of October 16, 2026 at EUR 261.50. The modest spread leaves the October 29 results date as the next quantified test for the stock.

The further course of trading is shown by the continuously updated real-time quote of Stryker stock.